Health Sciences Research

Research Output 1993 2019

Filter
Letter
2019

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Multiple Myeloma
2018
3 Citations (Scopus)

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Ghesquières, H., Larrabee, B. R., Casasnovas, O., Maurer, M. J., McKay, J. D., Ansell, S. M., Montgomery, D., Asmann, Y., Farrell, K., Verney, A., Slager, S. L., Allmer, C., Perrot, A., Delarue, R., Habermann, T. M., Dupuis, J., Link, B. K., Canioni, D., Dogan, A., Cozen, W. & 3 others, Jarrett, R. F., Cerhan, J. R. & Salles, G., Jan 1 2018, In : British Journal of Haematology. 180, 2, p. 286-290 5 p.

Research output: Contribution to journalLetter

Leupeptins
Long Noncoding RNA
Chromosomes, Human, Pair 8
myc Genes
Genetic Loci
5 Citations (Scopus)

Targetable fusions of the FRK tyrosine kinase in ALKnegative anaplastic large cell lymphoma

Hu, G., Dasari, S., Asmann, Y., Greipp, P. T., Knudson, R. A., Benson, H. K., Li, Y., Eckloff, B. W., Jen, J., Link, B. K., Jiang, L., Sidhu, J. S., Wellik, L. E., Witzig, T. E., Bennani, N., Cerhan, J. R., Luchtel, R. & Feldman, A. L., Feb 1 2018, In : Leukemia. 32, 2, p. 565-569 5 p.

Research output: Contribution to journalLetter

Anaplastic Large-Cell Lymphoma
Protein-Tyrosine Kinases
2017
4 Citations (Scopus)
Exome
Lymphoma, Large B-Cell, Diffuse
2015
3 Citations (Scopus)

Comment on: The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma-Implications on the t-classification system

Jambusaria-Pahlajani, A., Karia, P. S., Parker, A. & Schmults, C. D., Mar 1 2015, In : Journal of Surgical Oncology. 111, 4, p. 483-484 2 p.

Research output: Contribution to journalLetter

Neoplasm Staging
Skin Neoplasms
Squamous Cell Carcinoma
Neoplasm Metastasis
Skin

Reply to M.J. Mourits et al

Sherman, M. E., Piedmonte, M., Mai, P. L. & Greene, M. H., May 1 2015, In : Journal of Clinical Oncology. 33, 13, p. 1515 1 p.

Research output: Contribution to journalLetter

Fallopian Tube Neoplasms
Unknown Primary Neoplasms
Ovarian Neoplasms
Breast Neoplasms

Response

Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M. & Sherman, M. E., Apr 1 2015, In : Journal of the National Cancer Institute. 107, 4

Research output: Contribution to journalLetter

Neoplasm Proteins
Tumor Biomarkers
Breast Neoplasms
2013

Response

Sahasrabuddhe, V. V. & Sherman, M. E., May 1 2013, In : Journal of the National Cancer Institute. 105, 9, p. 665-666 2 p.

Research output: Contribution to journalLetter

2012
1 Citation (Scopus)

Learning from disease heterogeneity

Gaudet, M. M., Sherman, M. E. & Thun, M. J., Sep 2012, In : The Lancet Oncology. 13, 9, p. 862-863 2 p.

Research output: Contribution to journalLetter

Mucinous Adenocarcinoma
Ovarian Neoplasms
Smoking
Learning
2011
Combined Modality Therapy
Cryosurgery
Brachytherapy
Robotics
Prostatectomy
2007
2 Citations (Scopus)
Kidney Neoplasms
Renal Cell Carcinoma
Alcohol Drinking
Canada
Epidemiology
2006
5 Citations (Scopus)

Clarifying breast cancer risks associated with menopausal hormone therapy

Garcia-Closas, M., Sherman, M. E. & Brinton, L. A., Nov 2006, In : Lancet Oncology. 7, 11, p. 885-886 2 p.

Research output: Contribution to journalLetter

Estrogen Replacement Therapy
Menopause
Clinical Trials
Hormones
Breast Neoplasms

Reply: Study design and statistics in epidemiology of breast cancer [2]

Garcia-Closas, M., Brinton, L. A., Anderson, W. F. & Sherman, M. E., Nov 6 2006, In : British Journal of Cancer. 95, 9, p. 1302-1303 2 p.

Research output: Contribution to journalLetter

Epidemiology
Breast Neoplasms
2005
2 Citations (Scopus)

Re: The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? [8] (multiple letters)

Stamey, T. A., Caldwell, M., McNeal, J. E., Nolley, R., Hemenez, M., Downs, J., Rosser, C. J., Parker, A. & Lynch, M. J., Sep 2005, In : Journal of Urology. 174, 3, p. 1154-1156 3 p.

Research output: Contribution to journalLetter

Predictive Value of Tests
Mass Screening
Neoplasm Staging
Prostate-Specific Antigen
Tumor Biomarkers
2002
1 Citation (Scopus)

Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women [1] (multiple letters)

Burry, K., Cain, J. M., Gilbert, L., Krishnamurthy, S., Tan, S. L., Franco, E. L., Lacey, J. V., Mink, P. J., Lubin, J. H., Sherman, M. E., Troisi, R., Hartge, P., Schatzkin, A. & Schairer, C., Nov 27 2002, In : Journal of the American Medical Association. 288, 20, p. 2538-2539 2 p.

Research output: Contribution to journalLetter

Postmenopause
Estrogen Replacement Therapy
Progestins
Ovarian Neoplasms
Ovary
2000
1 Citation (Scopus)
Papillomaviridae
Tumor Virus Infections
Uterine Cervical Dysplasia
Vaginal Smears
Cervical Intraepithelial Neoplasia
1993
3 Citations (Scopus)

Response

Schiffman, M. H., Manos, M. M., Sherman, M. E., Scott, D. R. & Glass, A. G., Nov 17 1993, In : Journal of the National Cancer Institute. 85, 22, p. 1868-1870 3 p.

Research output: Contribution to journalLetter